News

Bright Minds Biosciences Showcases Presentations at Global Conferences

Bright Minds Biosciences Showcases Presentations at Global Conferences

Bright Minds Biosciences Highlights Upcoming Conference Presentations

Bright Minds Biosciences, Inc. (NASDAQ: DRUG), is a leader in the biotechnology field, specializing in the development of innovative treatments for challenging neurological and psychiatric disorders. With a commitment to addressing the needs of patients suffering from conditions such as epilepsy and depression, the company is set to present at several notable events.

Scheduled Conference Appearances

The following is a list of conferences where Bright Minds Biosciences will be making presentations:

International Epilepsy Congress

Bright Minds will participate in the 36th International Epilepsy Congress taking place at the Lisboa Congress Centre. This event offers a vital opportunity to share insights and advancements in the treatment of epilepsy with fellow professionals and stakeholders in the field.

Cantor Global Healthcare Conference

Another key event on the schedule is the Cantor Global Healthcare Conference, set for September 5, 2025. Bright Minds will feature prominently in discussions and presentations at this event, showcasing its innovative research and commitment to patient care. The live webcast of this event will be accessible on their official website, allowing shareholders and interested parties to engage with the company's developments.

H.C. Wainwright Annual Global Investment Conference

On September 9, 2025, Bright Minds will also attend the H.C. Wainwright 27th Annual Global Investment Conference to expand its investor outreach efforts and discuss its financial strategy, including the progress of its drug candidates. This platform aids in aligning investor expectations with the company's visionary goals.

Baird Global Healthcare Conference

Furthering engagement in the healthcare investment community, Bright Minds will present at the Baird 2025 Global Healthcare Conference on September 10, 2025. This conference is instrumental in fostering relationships with potential investors and industry partners, enhancing market visibility and opportunity.

Innovative Approach to Therapeutics

At the heart of Bright Minds Biosciences' mission is a robust pipeline of unique compounds designed to target crucial receptors in the brain. The focus is on developing highly selective 5-HT2 agonists which offer promise in treating drug-resistant forms of epilepsy and other central nervous system disorders. Their commitment to addressing high unmet medical needs sets them apart in the crowded biotechnology landscape.

The Company’s Vision

Through its proprietary platform, Bright Minds is dedicated to delivering breakthrough therapies that can significantly change the lives of patients. The company's advancements hinge on rigorous research paired with innovative drug development, focusing primarily on the neurological and psychiatric fields.

Investor Relations Contact

For inquiries related to investments and corporate communications, Bright Minds encourages stakeholders to reach out to their Investor Relations team. Lisa M. Wilson, their designated contact, is available at 212-452-2793 or via email. Additionally, Alex Vasilkevich, the Chief Operating Officer, welcomes direct engagement regarding operational matters.

Frequently Asked Questions

What is the primary focus of Bright Minds Biosciences?

The primary focus of Bright Minds Biosciences is developing highly selective 5-HT2 agonists for treating various neurological and psychiatric disorders.

What upcoming conferences will Bright Minds attend?

Bright Minds will present at the International Epilepsy Congress and several key healthcare conferences in September 2025.

How can investors follow Bright Minds' presentations?

Investors can access live webcasts of presentations on the Bright Minds official website and view archived content after events.

What therapeutic areas does Bright Minds target?

Bright Minds focuses on therapies for epilepsy, depression, and other central nervous system disorders where there are significant unmet clinical needs.

How can I contact Bright Minds for further questions?

You can contact Bright Minds' investor relations directly through Lisa M. Wilson at 212-452-2793 or via email for any inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 6

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading

Top 5 Most Recently Viewed Articles

Comprehensive Overview of Marlowe PLC's Latest Disclosure

Updated Category News Views 133

Understanding the Disclosure from Marlowe PLC The public opening position disclosure from Marlowe PLC brings vital information to investors and stakeholders. It serves as an essential document under the rules established by the Takeover Code. A disclosure like this outlines the interests stakeholders hold in relevant securities, especially when they represent 1% or...

Continue Reading
Harvard Extension School's Social Media Triumph at UPCEA

Updated Category News Views 210

Harvard Extension School's #HESProud Campaign Achievements The Harvard Extension School (HES) proudly announces its victory with the #HESProud social media campaign, honored as the GOLD recipient of the UPCEA's Excellence in Marketing Award for 2024. This notable accolade it received celebrates the campaign's creativity and engagement, which resonated significantly across...

Continue Reading
AI in CX: The Gap Between Hype and Reality

Updated Category News Views 5

AI in Customer Experience: Not Quite There Yet Let's dive into what TELUS Digital and Ryan Strategic Advisory's survey reveals: enterprises are tossing AI into their customer experience (CX) operations like confetti, yet they're fumbling when it comes to actually tracking if it’s doing any good. Most are relying on human agents propped up by AI, with a solid 61% rolling...

Continue Reading
Humana and Longevity Health Team Up to Boost Medicare Access

Updated Category News Views 108

Humana and Longevity Health Join Forces for Expanded Access In an important alliance, Humana Inc. (NYSE: HUM) and Longevity Health have unveiled a multi-state initiative set to enhance accessibility to Humana Together in Health, which is a Medicare Advantage Institutional Special Needs Plan (I-SNP). This collaboration focuses on providing personalized care to individuals...

Continue Reading
Key Ruling in Niger Delta Oil Pollution Issue by High Court

Updated Category News Views 299

Groundbreaking Judgment in Niger Delta Oil Pollution Case In a significant ruling, the English High Court addressed ongoing litigation regarding oil pollution in the Niger Delta, focusing specifically on the Bille and Ogale regions. This decision, delivered by Justice May, aims to clarify complex legal issues and streamline the upcoming trial process. Facing off in this...

Continue Reading